Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease

IntroductionThe goal of this study is to explore the pharmacological potential of the amyloid-reducing vasodilator fasudil, a selective Ras homolog (Rho)-associated kinases (ROCK) inhibitor, in the P301S tau transgenic mouse model (Line PS19) of neurodegenerative tauopathy and Alzheimer's disea...

Full description

Bibliographic Details
Main Authors:	Roberto Collu, Zheng Yin, Elisa Giunti, Sarah Daley, Mei Chen, Peter Morin, Richard Killick, Stephen T. C. Wong, Weiming Xia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Alzheimer's disease fasudil PS19 P301S tau proteomic
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2024.1323563/full

Similar Items

Erratum: Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease
by: Frontiers Production Office
Published: (2024-04-01)

Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice
by: Roberto Collu, et al.
Published: (2023-12-01)

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
by: Richard Killick, et al.
Published: (2023-07-01)

Fasudil reduces β-amyloid levels and neuronal apoptosis in APP/PS1 transgenic mice via inhibition of the Nogo-A/NgR/RhoA signaling axis
by: Min-Fang Guo, et al.
Published: (2020-12-01)

ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion
by: Li Hailing, et al.
Published: (2012-06-01)

Fasudil inhibits actin polymerization and collagen synthesis and induces apoptosis in human urethral scar fibroblasts via the Rho/ROCK pathway
by: Li XD, et al.
Published: (2018-09-01)

Fasudil Increased the Sensitivity to Gefitinib in NSCLC by Decreasing Intracellular Lipid Accumulation
by: Tingting Liao, et al.
Published: (2022-09-01)

Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
by: Fiona Grueninger, et al.
Published: (2010-02-01)

Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis
by: Jan C. Koch, et al.
Published: (2020-03-01)

Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice
by: Céline Héraud, et al.
Published: (2014-02-01)

Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro
by: Chengyu Xiang, et al.
Published: (2021-01-01)

Biochemical distribution of tau protein in synaptosomal fraction of transgenic mice expressing human P301L tau
by: Naruhiko eSahara, et al.
Published: (2014-03-01)

Fasudil mediates neuroprotection in ischemia/reperfusion by modulating the ROCK-PPARα-NOX axis
by: Xitong Yang, et al.
Published: (2023-12-01)

Fasudil and SR1001 synergistically protect against sepsis-associated pancreatic injury by inhibiting RhoA/ROCK pathway and Th17/IL-17 response
by: Pingping Liu, et al.
Published: (2023-09-01)

Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study
by: Sahba Fekri, et al.
Published: (2022-06-01)

Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning
by: Florian Eckenweber, et al.
Published: (2020-07-01)

Hydrochloride fasudil attenuates brain injury in ICH rats
by: Li Limin, et al.
Published: (2020-04-01)

Fasudil may alleviate alcohol-induced astrocyte damage by modifying lipid metabolism, as determined by metabonomics analysis
by: Huiying Zhao, et al.
Published: (2023-06-01)

Effects of fasudil on blood–brain barrier integrity
by: Kei Sato, et al.
Published: (2022-06-01)

Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
by: Raphael Mietzner, et al.
Published: (2020-07-01)

Pre-treatment With Fasudil Prevents Neomycin-Induced Hair Cell Damage by Reducing the Accumulation of Reactive Oxygen Species
by: Yanqiu Zhang, et al.
Published: (2019-11-01)

High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels
by: Ichinomiya Taiga, et al.
Published: (2012-03-01)

Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells
by: Zhang X, et al.
Published: (2018-02-01)

Exploring the Ocular Absorption Pathway of Fasudil Hydrochloride towards Developing a Nanoparticulate Formulation with Improved Performance
by: Barzan Osi, et al.
Published: (2024-01-01)

Fasudil Increases the Establishment of Somatic Cell Nuclear Transfer Embryonic Stem Cells in Mouse
by: Seongjun So, et al.
Published: (2020-03-01)

Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone
by: Xiao-lin Hou, et al.
Published: (2015-01-01)

Fasudil Attenuated 6-OHDA Cytotoxicity in PC12 Cells through Inhibition of JAK/STAT and Apoptosis Pathways
by: Samira Barangi, et al.
Published: (2023-04-01)

Fasudil in Combination With Bone Marrow Stromal Cells (BMSCs) Attenuates Alzheimer’s Disease-Related Changes Through the Regulation of the Peripheral Immune System
by: Jiezhong Yu, et al.
Published: (2018-07-01)

Effect of fasudil on experimental autoimmune neuritis and its mechanisms of action
by: Yanyin Zhao, et al.
Published: (2019-12-01)

Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease
by: Tang Y, et al.
Published: (2020-01-01)

ROCK inhibitor fasudil reduces the expression of inflammatory factors in LPS-induced rat pulmonary microvascular endothelial cells via ROS/NF-κB pathway
by: Huanlong Liu, et al.
Published: (2022-04-01)

Assessment of Fasudil on Contrast-Associated Acute Kidney Injury Using Multiparametric Renal MRI
by: Bin Wang, et al.
Published: (2022-06-01)

A ROCK1 Inhibitior Fasudil Alleviates Cardiomyocyte Apoptosis in Diabetic Cardiomyopathy by Inhibiting Mitochondrial Fission in a Type 2 Diabetes Mouse Model
by: Xinhui Fan, et al.
Published: (2022-07-01)

Relief of vasospasm with fasudil after off-pump coronary artery bypass grafting: a case study
by: Akira Fujita, et al.
Published: (2018-07-01)

Fasudil Stimulates Neurite Outgrowth and Promotes Differentiation in C17.2 Neural Stem Cells by Modulating Notch Signalling but not Autophagy
by: Shu Chen, et al.
Published: (2015-05-01)

Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma
by: Liu Y, et al.
Published: (2016-08-01)

Fasudil-modified macrophages reduce inflammation and regulate the immune response in experimental autoimmune encephalomyelitis
by: Chunyun Liu, et al.
Published: (2024-01-01)

Dl-3-n-Butylphthalide Reduces Cognitive Deficits and Alleviates Neuropathology in P301S Tau Transgenic Mice
by: Yanmin Chang, et al.
Published: (2021-02-01)

Inhibition of RhoA/Rho kinase signaling pathway by fasudil protects against kainic acid‐induced neurite injury
by: Yingchun Xiang, et al.
Published: (2021-08-01)

Identification of Fasudil as a collaborator to promote the anti-tumor effect of lenvatinib in hepatocellular carcinoma by inhibiting GLI2-mediated hedgehog signaling pathway
by: Yilan Huang, et al.
Published: (2024-02-01)